🔬 Our new Practice Essentials series offers concise, expert-authored guides to navigating diagnostic challenges in cytopathology—ideal for both trainees and seasoned pathologists! Explore the series: https://t.co/mhrXUm7BK5 @bfaquin @MichiyaNishino @MauroSaieg #CytoPath

New this week! | Molecular profiling of thyroid nodules on cytologic samples: Findings from an Italian multi-institutional cohort https://t.co/hIbsL9HJDQ #CytoPath @DianaEstherossi @pietro_tralongo

Imagine if everything in life was as good as gold. It’s easy to invest in, could help grow your wealth, and protect it too. A timeless asset that stands strong when others may not.

#OpenAccess review | Role of renal mass biopsy for diagnosis and management: Review of current trends and future directions https://t.co/2JXIpSZNj0 #CytoPath @bonnie_choy @NayarRitu

#OpenAccess review! | Role of renal mass biopsy for diagnosis and management: Review of current trends and future directions https://t.co/2JXIpSZNj0 #CytoPath @bonnie_choy @NayarRitu

💥Open Access! SOX17, a highly sensitive and specific marker, should be included in the workup of differential diagnosis of metastatic gynecologic carcinomas in #cytology specimens. https://t.co/aTW3gBB9Hq @SatturawarSwati @Aparwani_dpath @LiZaibo #CytoPath

Stir up the group chat with a "let’s go to Florida this weekend 😎”

🔬 By integrating cytomorphologic assessment with clinical correlation and these additional tools, pathologists can enhance diagnostic precision and optimize patient care. Revisit this exciting edition of Practice Essentials: https://t.co/ETByIwNQsf #CytoPath @cjvand

#OpenAccess! This May 2025 study demonstrates that digital cytopathology, particularly through the Techcyte SureView™ system, can improve laboratory workflow and performance. 🔬👌 https://t.co/CvMCZYasZB @RiveraRolonMD @JuanSantaMD #DigiPath #GynPath #CytoPath

#FreeAccess Review! The (2022) WHO Reporting System for #Pancreaticobiliary #Cytopathology: Overview and Summary. Includes new categories, features, pertinent ancillary studies, and more. https://t.co/dY8I5AAdFW @marthabpitman @MauroSaieg @mtsiddi @fcschmitt

New today in CytoSource! 📘 A new push to revive transperineal prostate biopsies https://t.co/GfZXqEJ7J1 Amid growing concerns over transrectal biopsy infections and antibiotic resistance, the case for a transperineal alternative is not yet a sure thing. #CytoPath @bfaquin

Train smarter, store freely - no egress fees on Cloudflare's R2 object storage.

Our Cyto-Rads series explores corresponding radiologic imaging and cytology findings for commonly encountered entities. Revisit the first edition dealing with pancreatic #CytoPath! https://t.co/HzYLjlto10 @MauroSaieg @mdlozanoe @TrieuMD

The findings of this study suggest that DICER1-mutant nodules are unlikely to be BRAF-mutant carcinomas. Further study of the molecular characteristics of DICER1-mutant FNAs will contribute to more accurate cytological diagnosis. https://t.co/l5wiC5rVd4 #CytoPath

⚡Selection of neuroendocrine markers in diagnostic workup of neuroendocrine neoplasms: The real-world data and machine learning model algorithms https://t.co/pWuKagJwIv #CytoPath @gcai1978 @yalepathology

A new editorial by Marc P. Pusztaszeri MD and @aakasharmand comments on the recent article by Kowalewski et al comparing the @WHO and @MilanSystem Reporting Systems for Salivary Gland #CytoPath. Read the editorial: https://t.co/SV8qj3JpqI

🚨FLIGHTSCOPE BLACK FRIDAY SALE $1,200 OFF Mevo Plus Golf Simulators!

🔬🦃 Happy Thanksgiving to all who celebrate. We're thankful for the authors, editors, and reviewers of Cancer Cytopathology for stuffing the journal with such great content! You're the baste in the biz! It's all gravy! What are you thankful for in #CytoPath?

📽️ This #CytoVideo features @Sara_Jiang describing her recent #OpenAccess review on thyroid cytologic-radiographic correlations written with @UCincyPath & @DukePathDept investigators. Read it here! https://t.co/wMvU9zH0cn @benWTmd #CytoPath

This study examines pericardial fluid evaluation, comparing cytology vs. surgical specimens for malignancy detection. Findings highlight diagnostic yield of cytology. https://t.co/y7MdrZrPmq @drElieTannous #CytoPath

New this week | The feasibility of low-cost portable microscopes as an alternative to standard microscopes for rapid on-site evaluation of FNA. https://t.co/XVcShJpFcc #CytoPath @AdeAdventitia @StanfordPath

Speak up. Spend freely. Tell Congress to create a de minimis tax exemption for Bitcoin that allows us to spend our money on gas, groceries, and everyday costs with no strings attached. Act today.

#OpenAccess! Cytomorphology and clinicopathologic correlation of TFE3-rearranged renal cell carcinoma Read the latest from Tieying Hou MD, PhD (@IUMedSchool) and Xiaoqi Lin MD, PhD (@NU_Pathology): https://t.co/jomsBVT3q9 #CytoPath

Exciting news: The @AmericanCancer Society Journals are now on YouTube! 📺 Visit our channel to watch our #CytoVideos and other content related to Cancer Cytopathology. New videos added regularly! Subscribe here: https://t.co/C6vniLPT7x @bfaquin #CytoPath

💡In this study, TRPS1 showed lower specificity as a breast immunomarker because of its expression in nonbreast tumors. https://t.co/nDzcovKHok #CytoPath @DonthiDeepak @Jenny_QiongGan @QQingDing

Free access! | The combination of ANXA10 and p53 may be useful for the detection of both low-grade urothelial carcinoma and high-grade urothelial carcinoma, and it has the potential to improve the diagnostic accuracy of urine #cytology. https://t.co/ZeTBpCRFcU #CytoPath

Chevron’s AI platform APOLO is transforming shale operations, with up to 20% more accurate production forecasts. Learn how APOLO helps us make smarter, faster decisions.